PRPF31 interacts with PRPH2 confirmed by co-immunoprecipitation and co-localization
Xiaoqiang Xiao1, Fangyi Ling1, Chong-Bo Chen1
1Joint Shantou International Eye Center, Shantou University & the Chinese University of Hong Kong, Shantou, China.
Biochemical and Biophysical Research Communications
|September 11, 2022
Summary
Protein interactions between PRPF31 and PRPH2, key genes in retinitis pigmentosa, were investigated. The study found that PRPF31 interacts with PRPH2, offering new insights into the disease
Area of Science:
- Genetics and Molecular Biology
- Ophthalmology
- Cell Biology
Background:
- Retinitis pigmentosa (RP) is a group of inherited retinal diseases.
- Mutations in PRPF31 and PRPH2 are known causes of RP.
- Both genes are implicated in maintaining rhodopsin balance, crucial for photoreceptor function.
Purpose of the Study:
- To investigate the co-expression and physical interaction between PRPF31 and PRPH2.
- To determine if PRPF31 and PRPH2 proteins co-localize within cells.
Main Methods:
- Transfection of HEK293T and APRE-19 cells with PRPF31 and PRPH2 expression vectors.
- Validation of gene expression using immunoblotting.
- Assessment of protein interaction via co-immunoprecipitation (Co-IP).
- Analysis of protein co-localization using immunofluorescence staining.
Main Results:
- Co-immunoprecipitation experiments demonstrated that PRPF31 can be precipitated using an anti-PRPH2 antibody, indicating a physical interaction.
- Immunofluorescence assays revealed co-localization of PRPF31 and PRPH2 in transfected cell lines (HEK293T, APRE-19) and in mouse retina.
- These findings confirm a direct interaction between the PRPF31 and PRPH2 proteins.
Conclusions:
- PRPF31 and PRPH2 interact physically and co-localize within retinal cells.
- This interaction may play a significant role in the pathogenesis of retinitis pigmentosa.
- Further research into this interaction could reveal novel therapeutic targets for RP.
